But, many recent would-be reformers -- piggybacking on the economic and political pressures of the biopharmaceutical and device industries -- have focused almost exclusively on bias created by product marketing and industry funding of organized medicine. Some verge on pontification, proposing or pretending that restrictions on industry participation in research, education, sampling, and marketing would cleanse medical practice and automatically improve patient care.
Tuesday, June 10, 2008
Concerned about conflicts of interest? Get real.
Many times in this blog I’ve criticized the selective and disingenuous nature of the outrage over medical conflicts of interest. John F. Kamp, PhD, JD, in a recent Medscape Video Commentary said it well: